|
|
The companies may have similar
products in their portfolios that strengthen the merged company
or they may present a competitive threat. Whatever the reason
a a global understanding of the companies business is required to make
a complete commercial assessment. In doing so a complete picture of
the major brands, their therapeutic classes, and the geographical
spread of the business is developed. A sales breakdown will
then reveal where the fit is advantageous and where weaknesses
exist
An evaluated analysis on how the company measures up at three
critical stages of the product lifecycle;
its ability to innovate, launch drugs and protect its intellectual
property, gives a further dimension to the company's suitability
as an M&A target. Understanding the candidates overall
strategy, and its fit with the acquiring
company, is vital research in the case for the acquisition.
Having collated the information, decision makers could examine
the potential new corporate entity to see what market share
it would have, and its ranking amongst the competition.
|
